Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 14, 2026
Sygnature Discovery has established a formal collaboration with X-Chem to support the delivery of DEL screening within its integrated drug discovery programs.
read more
Thursday, September 10, 2026
Shilpa CDMO, a contract development and manufacturing organization focused on complex small molecules, will launch as a separate brand from parent company Shilpa Medicare at CPHI Milan next month.
read more
Thursday, September 10, 2026
Lonza plans to build a commercial-scale spray-drying facility at its Bend, Oregon, site, expanding its capacity to develop and manufacture spray-dried pharmaceutical formulations.
read more
Thursday, September 10, 2026
Summit Clinical Research Solutions has acquired Dallas Research Institute through its Pinnacle Clinical Research site network, expanding its clinical-trial operations in the Dallas-Fort Worth market.
read more
Thursday, September 10, 2026
Quva Pharma has acquired a portfolio of sterile compounded medications from Central Admixture Pharmacy Services, or CAPS, after CAPS decided to exit the 503B sterile-compounding business.
read more
Thursday, September 10, 2026
CordenPharma plans to invest €80 million, or about $94 million, over multiple years to expand sterile injectable manufacturing at its Caponago site near Milan, Italy, with projected capacity of up to 500 million units annually.
read more
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB continuous bioprocessing platform and ExcelPro cell-culture media.
read more
Tuesday, September 08, 2026
AtomVie Global Radiopharma has opened a new radiopharmaceutical manufacturing facility in Hamilton, Ontario, following an investment of more than $160 million in a site the company says will expand production capacity by more than tenfold.
read more
Tuesday, September 08, 2026
Hovione Holding AG has appointed Stefan Doboczky as chief executive officer, effective April 1, 2027, moving the company’s current board chairman into its top operating role.
read more
Tuesday, September 08, 2026
Charles River Laboratories has brought a fully automated production suite for Endosafe bacterial endotoxin testing cartridges into full operation, increasing manufacturing capacity and adding inspection and digital-traceability functions.
read more
Tuesday, September 08, 2026
Onyx Scientific will invest more than £1.5 million, or about $2 million, to expand commercial active pharmaceutical ingredient manufacturing capacity at its Sunderland, United Kingdom, facility.
read more
Thursday, September 03, 2026
The Advanced Research Projects Agency for Health has selected five teams for a program intended to develop automated, distributed manufacturing systems for individualized RNA-based genetic medicines, with up to $125 million available for research and...
read more
Thursday, September 03, 2026
Fortrea Holdings has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at about $45 million, adding a Texas clinical pharmacology unit, bioanalytical laboratory and biospecimen storage ...
read more
Thursday, September 03, 2026
Northway Biotech has opened a $72 million cell-therapy and personalized-medicine contract development and manufacturing facility in Vilnius, Lithuania, expanding its capacity to develop and produce advanced therapies.
read more
Thursday, September 03, 2026
Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed injectable drug product, adding what the company expects could become one of its largest commercial ...
read more